Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stabilized plasmid-lipid particles: a systemic gene therapy vector.

David B Fenske1, Ian MacLachlan, Pieter R Cullis

  • 1Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z3.

Methods in Enzymology
|March 9, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Liposomal lipid nanoparticles containing dihydrosphingomyelin exhibit improved stability and extended hepatic and extrahepatic transfection.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Direct Counting of mRNA Copies Inside Individual Lipid Nanoparticles Using In Situ Lysis and Labeling.

Analytical chemistry·2026
Same author

Hybrid Lipid Nanoparticles Containing Iron Oxide Nanoparticles and Doxorubicin.

Langmuir : the ACS journal of surfaces and colloids·2026
Same author

Silencing of PAI-1 using siRNA-lipid nanoparticles reduces thrombosis and prolongs life span in murine models.

Blood·2026
Same author

Single-Particle Multiparametric Microscopy Reveals Structural, Size, and Payload Heterogeneity in mRNA-Loaded Lipid Nanoparticles.

ACS nano·2025
Same author

Lipid nanoparticle mediated base editing of the Q344X rhodopsin mutation associated with retinitis pigmentosa.

Gene therapy·2025
Same journal

Clinical Europium fluorescent based lectin assays for mucin O-glycomics.

Methods in enzymology·2026
Same journal

A dual-color FRET assay for detection and quantitative analysis of O-glycopeptidases.

Methods in enzymology·2026
Same journal

Evolutionary genetic approaches to analyze mucins.

Methods in enzymology·2026
Same journal

Ex vivo imaging and enzymatic analysis of intestinal mucus.

Methods in enzymology·2026
Same journal

Glyco-TRAPP: A real-time glycocalyx permeability assay for assessing transmembrane mucin barrier function in live and fixed tissues.

Methods in enzymology·2026
Same journal

Quantitative imaging approaches to capture structural and functional dynamics of colonic mucus in health and disease in situ.

Methods in enzymology·2026
See all related articles

Systemic lipid particle (SPLP) gene therapy offers extended circulation and tumor accumulation for effective transgene expression. Optimizing PEG-ceramide anchors enhances tumor delivery and transfection, showcasing SPLP

Area of Science:

  • Gene Therapy
  • Nanotechnology
  • Pharmacology

Background:

  • Systemic gene therapy requires vectors with long circulation times for tumor accumulation.
  • Current PEGylated lipid-based particles (SPLP) show promise but face challenges in balancing circulation and transfection.
  • PEG coatings are crucial for circulation but can hinder cellular uptake.

Purpose of the Study:

  • To optimize SPLP for enhanced tumor gene delivery and transfection.
  • To investigate the role of PEG-ceramide anchor length in SPLP pharmacokinetics and biodistribution.
  • To evaluate SPLP as a non-toxic systemic gene therapy platform.

Main Methods:

  • Systemic administration of SPLP in a murine tumor model.
  • Modulation of PEG-ceramide dissociation rates by varying acyl chain length.

Related Experiment Videos

  • Assessment of circulation lifetime, tumor accumulation, and transgene expression.
  • Comparison of SPLP with other plasmid encapsulation methods.

    • Main Results:

    • SPLP demonstrated extended circulation, distal tumor accumulation, and transgene expression.
    • The SPLP-CerC20 system, with minimal PEG-Cer dissociation, showed superior serum stability, circulation, and tumor gene expression.
    • SPLP achieved higher plasmid DNA-to-lipid ratios compared to other encapsulation methods.

    Conclusions:

    • SPLP is a flexible and non-toxic platform for systemic gene therapy.
    • Optimizing PEG-ceramide anchors is critical for balancing tumor delivery and transfection efficiency.
    • SPLP holds significant potential for developing effective systemic gene therapies.